Proteomics is the large-scale study of proteins, particularly their structures and functions. Proteins are vital parts of living organisms, as they are the main components of the physiological metabolic pathways of cells. The transformation of the biopharmaceutical industry’s focus from genomics to system biology has enormously increased the importance of proteomics.
The need to develop more reliable and cost-effective drugs and increasing emphasis on personalized medicines are necessitating in-depth research on proteomics. The growing awareness of protein study and research has opened up the market for various proteomic-related technologies, equipment, and services.
This research report divides proteomics market into four major segments, namely, instrumentation technology, reagents, applications and services. Increasing innovations and developments in the field of proteomics instrumentation, availability of funds from various organizations, and increasing research and development expenditure is driving the growth of the instrumentation and reagents market.
The geographies covered in this study are North America (U.S., Canada, Mexico), Europe (U.K., France, Italy, The Netherlands, Spain), Asia-Pacific (China, Japan, Australia, New Zealand), and Rest of the World (Africa, Latin America, Middle East). North America is the largest market for proteomics, with the U.S. taking the lion’s share, followed by Europe, and Asia
This report provides comprehensive analysis of more than 25 top players of Proteomics industry with respect to their company overview, financials, portfolio, recent developments and strategies.
Source: Expert Interviews, Government Authorities, Related associations/Institutes, Related Research Publication, Government Publication, Company Press Release, Company Annual Reports, Company Website, Company Publication, SEC Filings, Meticulous Analysis.
COVID-19
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
1 Introduction
- 1.1 Market Ecosystem
- 1.2 Report Elucidation
- 1.3 Market Buzz & Foreground
- 1.4 Research Methodology
- 1.4.1 Secondary Research
- 1.4.2 Primary Research
- 1.4.3 Market Analytics
2 Executive Summary
3 Market Insights
- 3.1 Drivers
- 3.2 Restraints
- 3.3 Opportunities
- 3.4 Challenges
- 3.5 Market Share Analysis
- 3.6 Market Trends
- 3.7 Burning Issues
4 Global Proteomics Market Analysis- Technology
- 4.1 Microarray
- 4.1.1 Biochips
- 4.1.1.1 Protein Chips
- 4.1.1.2 Lab-on-chips (Microfluidics)
- 4.1.2 Microarray instruments
- 4.1.2.1 Integrated Systems
- 4.1.2.2 Arrayers
- 4.1.2.3 Microarray Scanners
- 4.2 Spectroscopy
- 4.2.1 Mass Spectrometry
- 4.2.2 NMR Spectroscopy
- 4.2.3 Circular Dichroism (CD) Spectroscopy
- 4.3 X-RAY Crystallography
- 4.4 Chromatography
- 4.4.1 HPLC Systems
- 4.4.2 Ion Chromatography
- 4.4.3 Affinity Chromatography
- 4.4.4 Supercritical Fluid Chromatography
- 4.5 Electrophoresis
- 4.5.1 Gel Electrophoresis
- 4.5.2 Capillary Electrophoresis
- 4.6 Surface Plasmon Resonance (SPR) Systems
- 4.7 Protein Fractionation Systems
5 Global Proteomics Market Analysis- Services
- 5.1 Analytical Laboratory Services
- 5.1.1 Protein identification
- 5.1.2 Protein separation
- 5.1.3 Protein sequencing
- 5.2 Data Analysis & Maintenance
- 5.2.1 Bioinformatics databases
- 5.2.2 Bioinformatics tools
6 Global Proteomics Market Analysis- Reagent
- 6.1 Microarray
- 6.2 Spectroscopy
- 6.3 X-ray Crystallography
- 6.4 Chromatography
- 6.5 Electrophoresis
- 6.6 Immunoassay
- 6.7 Microsphere
- 6.8 Protein Fractionation reagents
7 Global Proteomics Market Analysis- Application
- 7.1 Drug discovery
- 7.2 Diagnosis
- 7.3 Others
8 Proteomics Market Analysis- Geography
- 8.1 North America
- 8.1.1U.S.
- 8.1.2Canada
- 8.2 Europe
- 8.2.1 Germany
- 8.2.2 France
- 8.2.3 U.K.
- 8.2.4 Italy
- 8.2.5 Spain
- 8.2.6 RoE
- 8.3 Asia-Pacific
- 8.3.1 Japan
- 8.3.2China
- 8.3.3Australia
- 8.3.4 Newzealand
- 8.3.5India
- 8.3.6RoAP
- 8.4 RoW
- 8.4.1Latin America (LATAM)
- 8.4.2Middle East & Africa
9 Company profiles
- 9.1 Affymetrix
- 9.2 Agilent technologies
- 9.3 Becton, dickinson and company
- 9.4 Beckman coulter
- 9.5 Bio-rad laboratories
- 9.6 bruker corporation
- 9.7 Capiler life Sciences
- 9.8 Danaher Corporation
- 9.9 Illumina Inc
- 9.1 Life technologies Corporation
- 9.11 Lifespan biosciences,inc
- 9.12 Merck millipore
- 9.13 Perkinelmer inc
- 9.14 Promega Corporation
- 9.15 Protagen AG
- 9.16 Protea Biosciences Group
- 9.17 Shimadzu corporation
- 9.18 Sigma-aldrich Corporation
- 9.19 Thermo Fisher Scientific,Inc
- 9.20 Waters Corporation
10 Competitive Landscape
- 10.1 Introduction
- 10.2 Agreements, Partnerships & Collaborations
- 10.3 Investments & Expansions
- 10.4 Key Market Strategies
- 10.5 Mergers & Acquisitions
- 10.6 New Products Launch – Most Preferred Strategic Approach
COVID-19
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
COVID-19
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
